 | • レポートコード：MRC2Q12-00801 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、アシクロビルAPIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 アシクロビルAPIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 アシクロビルAPIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 アシクロビルAPIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのアシクロビルAPIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のアシクロビルAPIの売上および2028年までの予測に焦点を当てています。 アシクロビルAPIのグローバル主要企業には、Kyung Dong Pharm、Shiono Chemical、Index Pharmaceutical、Sinolite Industrial、Mac-Chem、Newedge Overseas、Zhejiang Chetou Pharmaceutical、Hainan Poly Pharm、Zhejiang Zhebei Pharmaceutical、Hubei Yitai Pharmaceutical、Hubei Hongyuan Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 アシクロビルAPI市場は、タイプとアプリケーションによって区分されます。世界のアシクロビルAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 純度≥98%、純度≥99% 【アプリケーション別セグメント】 注射液、軟膏、錠剤、カプセル剤、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - アシクロビルAPI製品概要 - タイプ別市場（純度≥98%、純度≥99%） - アプリケーション別市場（注射液、軟膏、錠剤、カプセル剤、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のアシクロビルAPI販売量予測2017-2028 - 世界のアシクロビルAPI売上予測2017-2028 - アシクロビルAPIの地域別販売量 - アシクロビルAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別アシクロビルAPI販売量 - 主要メーカー別アシクロビルAPI売上 - 主要メーカー別アシクロビルAPI価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（純度≥98%、純度≥99%） - アシクロビルAPIのタイプ別販売量 - アシクロビルAPIのタイプ別売上 - アシクロビルAPIのタイプ別価格 ・アプリケーション別市場規模（注射液、軟膏、錠剤、カプセル剤、その他） - アシクロビルAPIのアプリケーション別販売量 - アシクロビルAPIのアプリケーション別売上 - アシクロビルAPIのアプリケーション別価格 ・北米市場 - 北米のアシクロビルAPI市場規模（タイプ別、アプリケーション別） - 主要国別のアシクロビルAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのアシクロビルAPI市場規模（タイプ別、アプリケーション別） - 主要国別のアシクロビルAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のアシクロビルAPI市場規模（タイプ別、アプリケーション別） - 主要国別のアシクロビルAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のアシクロビルAPI市場規模（タイプ別、アプリケーション別） - 主要国別のアシクロビルAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのアシクロビルAPI市場規模（タイプ別、アプリケーション別） - 主要国別のアシクロビルAPI市場規模（トルコ、サウジアラビア） ・企業情報 Kyung Dong Pharm、Shiono Chemical、Index Pharmaceutical、Sinolite Industrial、Mac-Chem、Newedge Overseas、Zhejiang Chetou Pharmaceutical、Hainan Poly Pharm、Zhejiang Zhebei Pharmaceutical、Hubei Yitai Pharmaceutical、Hubei Hongyuan Pharmaceutical ・産業チェーン及び販売チャネル分析 - アシクロビルAPIの産業チェーン分析 - アシクロビルAPIの原材料 - アシクロビルAPIの生産プロセス - アシクロビルAPIの販売及びマーケティング - アシクロビルAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - アシクロビルAPIの産業動向 - アシクロビルAPIのマーケットドライバー - アシクロビルAPIの課題 - アシクロビルAPIの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Acyclovir API Market
Due to the COVID-19 pandemic, the global Acyclovir API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥ 98% accounting for % of the Acyclovir API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Injection Solution segment is altered to an % CAGR throughout this forecast period.
China Acyclovir API market size is valued at US$ million in 2021, while the US and Europe Acyclovir API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Acyclovir API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Acyclovir API include Kyung Dong Pharm, Shiono Chemical, Index Pharmaceutical, Sinolite Industrial, Mac-Chem, Newedge Overseas, Zhejiang Chetou Pharmaceutical, Hainan Poly Pharm and Zhejiang Zhebei Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Acyclovir API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Acyclovir API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Acyclovir API Scope and Segment
Acyclovir API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Acyclovir API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥ 98%
Purity ≥ 99%
Segment by Application
Injection Solution
Ointment
Tablets
Capsules
Other
By Company
Kyung Dong Pharm
Shiono Chemical
Index Pharmaceutical
Sinolite Industrial
Mac-Chem
Newedge Overseas
Zhejiang Chetou Pharmaceutical
Hainan Poly Pharm
Zhejiang Zhebei Pharmaceutical
Hubei Yitai Pharmaceutical
Hubei Hongyuan Pharmaceutical
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Acyclovir API Product Introduction
1.2 Market by Type
1.2.1 Global Acyclovir API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥ 98%
1.2.3 Purity ≥ 99%
1.3 Market by Application
1.3.1 Global Acyclovir API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Injection Solution
1.3.3 Ointment
1.3.4 Tablets
1.3.5 Capsules
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Acyclovir API Production
2.1 Global Acyclovir API Production Capacity (2017-2028)
2.2 Global Acyclovir API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Acyclovir API Production by Region
2.3.1 Global Acyclovir API Historic Production by Region (2017-2022)
2.3.2 Global Acyclovir API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Acyclovir API Sales in Volume & Value Estimates and Forecasts
3.1 Global Acyclovir API Sales Estimates and Forecasts 2017-2028
3.2 Global Acyclovir API Revenue Estimates and Forecasts 2017-2028
3.3 Global Acyclovir API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Acyclovir API Sales by Region
3.4.1 Global Acyclovir API Sales by Region (2017-2022)
3.4.2 Global Sales Acyclovir API by Region (2023-2028)
3.5 Global Acyclovir API Revenue by Region
3.5.1 Global Acyclovir API Revenue by Region (2017-2022)
3.5.2 Global Acyclovir API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Acyclovir API Production Capacity by Manufacturers
4.2 Global Acyclovir API Sales by Manufacturers
4.2.1 Global Acyclovir API Sales by Manufacturers (2017-2022)
4.2.2 Global Acyclovir API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Acyclovir API in 2021
4.3 Global Acyclovir API Revenue by Manufacturers
4.3.1 Global Acyclovir API Revenue by Manufacturers (2017-2022)
4.3.2 Global Acyclovir API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Acyclovir API Revenue in 2021
4.4 Global Acyclovir API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Acyclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Acyclovir API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Acyclovir API Sales by Type
5.1.1 Global Acyclovir API Historical Sales by Type (2017-2022)
5.1.2 Global Acyclovir API Forecasted Sales by Type (2023-2028)
5.1.3 Global Acyclovir API Sales Market Share by Type (2017-2028)
5.2 Global Acyclovir API Revenue by Type
5.2.1 Global Acyclovir API Historical Revenue by Type (2017-2022)
5.2.2 Global Acyclovir API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Acyclovir API Revenue Market Share by Type (2017-2028)
5.3 Global Acyclovir API Price by Type
5.3.1 Global Acyclovir API Price by Type (2017-2022)
5.3.2 Global Acyclovir API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Acyclovir API Sales by Application
6.1.1 Global Acyclovir API Historical Sales by Application (2017-2022)
6.1.2 Global Acyclovir API Forecasted Sales by Application (2023-2028)
6.1.3 Global Acyclovir API Sales Market Share by Application (2017-2028)
6.2 Global Acyclovir API Revenue by Application
6.2.1 Global Acyclovir API Historical Revenue by Application (2017-2022)
6.2.2 Global Acyclovir API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Acyclovir API Revenue Market Share by Application (2017-2028)
6.3 Global Acyclovir API Price by Application
6.3.1 Global Acyclovir API Price by Application (2017-2022)
6.3.2 Global Acyclovir API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Acyclovir API Market Size by Type
7.1.1 North America Acyclovir API Sales by Type (2017-2028)
7.1.2 North America Acyclovir API Revenue by Type (2017-2028)
7.2 North America Acyclovir API Market Size by Application
7.2.1 North America Acyclovir API Sales by Application (2017-2028)
7.2.2 North America Acyclovir API Revenue by Application (2017-2028)
7.3 North America Acyclovir API Sales by Country
7.3.1 North America Acyclovir API Sales by Country (2017-2028)
7.3.2 North America Acyclovir API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Acyclovir API Market Size by Type
8.1.1 Europe Acyclovir API Sales by Type (2017-2028)
8.1.2 Europe Acyclovir API Revenue by Type (2017-2028)
8.2 Europe Acyclovir API Market Size by Application
8.2.1 Europe Acyclovir API Sales by Application (2017-2028)
8.2.2 Europe Acyclovir API Revenue by Application (2017-2028)
8.3 Europe Acyclovir API Sales by Country
8.3.1 Europe Acyclovir API Sales by Country (2017-2028)
8.3.2 Europe Acyclovir API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Acyclovir API Market Size by Type
9.1.1 Asia Pacific Acyclovir API Sales by Type (2017-2028)
9.1.2 Asia Pacific Acyclovir API Revenue by Type (2017-2028)
9.2 Asia Pacific Acyclovir API Market Size by Application
9.2.1 Asia Pacific Acyclovir API Sales by Application (2017-2028)
9.2.2 Asia Pacific Acyclovir API Revenue by Application (2017-2028)
9.3 Asia Pacific Acyclovir API Sales by Region
9.3.1 Asia Pacific Acyclovir API Sales by Region (2017-2028)
9.3.2 Asia Pacific Acyclovir API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Acyclovir API Market Size by Type
10.1.1 Latin America Acyclovir API Sales by Type (2017-2028)
10.1.2 Latin America Acyclovir API Revenue by Type (2017-2028)
10.2 Latin America Acyclovir API Market Size by Application
10.2.1 Latin America Acyclovir API Sales by Application (2017-2028)
10.2.2 Latin America Acyclovir API Revenue by Application (2017-2028)
10.3 Latin America Acyclovir API Sales by Country
10.3.1 Latin America Acyclovir API Sales by Country (2017-2028)
10.3.2 Latin America Acyclovir API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Acyclovir API Market Size by Type
11.1.1 Middle East and Africa Acyclovir API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Acyclovir API Revenue by Type (2017-2028)
11.2 Middle East and Africa Acyclovir API Market Size by Application
11.2.1 Middle East and Africa Acyclovir API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Acyclovir API Revenue by Application (2017-2028)
11.3 Middle East and Africa Acyclovir API Sales by Country
11.3.1 Middle East and Africa Acyclovir API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Acyclovir API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Kyung Dong Pharm
12.1.1 Kyung Dong Pharm Corporation Information
12.1.2 Kyung Dong Pharm Overview
12.1.3 Kyung Dong Pharm Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Kyung Dong Pharm Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Kyung Dong Pharm Recent Developments
12.2 Shiono Chemical
12.2.1 Shiono Chemical Corporation Information
12.2.2 Shiono Chemical Overview
12.2.3 Shiono Chemical Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Shiono Chemical Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Shiono Chemical Recent Developments
12.3 Index Pharmaceutical
12.3.1 Index Pharmaceutical Corporation Information
12.3.2 Index Pharmaceutical Overview
12.3.3 Index Pharmaceutical Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Index Pharmaceutical Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Index Pharmaceutical Recent Developments
12.4 Sinolite Industrial
12.4.1 Sinolite Industrial Corporation Information
12.4.2 Sinolite Industrial Overview
12.4.3 Sinolite Industrial Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Sinolite Industrial Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Sinolite Industrial Recent Developments
12.5 Mac-Chem
12.5.1 Mac-Chem Corporation Information
12.5.2 Mac-Chem Overview
12.5.3 Mac-Chem Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Mac-Chem Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Mac-Chem Recent Developments
12.6 Newedge Overseas
12.6.1 Newedge Overseas Corporation Information
12.6.2 Newedge Overseas Overview
12.6.3 Newedge Overseas Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Newedge Overseas Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Newedge Overseas Recent Developments
12.7 Zhejiang Chetou Pharmaceutical
12.7.1 Zhejiang Chetou Pharmaceutical Corporation Information
12.7.2 Zhejiang Chetou Pharmaceutical Overview
12.7.3 Zhejiang Chetou Pharmaceutical Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Zhejiang Chetou Pharmaceutical Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Zhejiang Chetou Pharmaceutical Recent Developments
12.8 Hainan Poly Pharm
12.8.1 Hainan Poly Pharm Corporation Information
12.8.2 Hainan Poly Pharm Overview
12.8.3 Hainan Poly Pharm Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Hainan Poly Pharm Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Hainan Poly Pharm Recent Developments
12.9 Zhejiang Zhebei Pharmaceutical
12.9.1 Zhejiang Zhebei Pharmaceutical Corporation Information
12.9.2 Zhejiang Zhebei Pharmaceutical Overview
12.9.3 Zhejiang Zhebei Pharmaceutical Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Zhejiang Zhebei Pharmaceutical Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Zhejiang Zhebei Pharmaceutical Recent Developments
12.10 Hubei Yitai Pharmaceutical
12.10.1 Hubei Yitai Pharmaceutical Corporation Information
12.10.2 Hubei Yitai Pharmaceutical Overview
12.10.3 Hubei Yitai Pharmaceutical Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Hubei Yitai Pharmaceutical Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Hubei Yitai Pharmaceutical Recent Developments
12.11 Hubei Hongyuan Pharmaceutical
12.11.1 Hubei Hongyuan Pharmaceutical Corporation Information
12.11.2 Hubei Hongyuan Pharmaceutical Overview
12.11.3 Hubei Hongyuan Pharmaceutical Acyclovir API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Hubei Hongyuan Pharmaceutical Acyclovir API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Hubei Hongyuan Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Acyclovir API Industry Chain Analysis
13.2 Acyclovir API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Acyclovir API Production Mode & Process
13.4 Acyclovir API Sales and Marketing
13.4.1 Acyclovir API Sales Channels
13.4.2 Acyclovir API Distributors
13.5 Acyclovir API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Acyclovir API Industry Trends
14.2 Acyclovir API Market Drivers
14.3 Acyclovir API Market Challenges
14.4 Acyclovir API Market Restraints
15 Key Finding in The Global Acyclovir API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer